Skip to main navigation
Main Menu
About
Overview
Amgen History
Mission and Values
Leadership
Awards and Accolades
How We Operate
Overview
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Science
Overview
Research and Development Strategy
Pipeline
Scientific Advisory Boards
Amgen Science
Amgen Competitive Grants
Biosimilars
Clinical Trials
Overview
About Clinical Trails
Amgen Clinical Trails
Clinical Study Report Synopses
Clinical Trial Diversity
Lay Summary of Clinical Trail Result
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support program
Investigator Sponsored Studies
Scientific Community Initiatives
Overview
Educational Outreach Program
Postdoctoral Fellows Program
Scientific Conferences Program
Start-Up Network Program
Manufacturing
Overview
Innovation
Quality
Reliability
PRODUCTS
Overview
Medical Information
Counterfeit Drug Statement
Safety Data Sheets
Global Patient Safety
Overview
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
Responsibility
Overview
2019 Responsibility Highlights Report
Corporate Responsibility
Strategy & Governance
Overview
Amgen’s Commitment to Patients
Our Approach to Pricing,
Access and Affordability
Overview
Access to Medicine
Diversity, Inclusion and Belonging
Amgen Foundation
Overview
Programs for Students
Programs for Teachers
About the Amgen Foundation
Commitment to Community
Overview
Amgen Foundation Grants
Independent Medical Education Funding
Non-Healthcare Donations and Sponsorships
U.S. Healthcare Donations
Equipment Donations
Donation and Grant Recipients
Staff Engagement
Environment
Overview
Performance
2020 Plan
Sustainable by Design
Case Studies
Responsible Sourcing
Workplace
Reporting and Metrics
Overview
Archived Reports
Summary of Data
CDP
Stakeholder Engagement
Stories
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities
Newsroom
Partners
Investors
Careers
Amgen Worldwide
Overview
Research and Development Strategy
Overview <i class="fa fa-external-link"></i>
Scientific Advisory Boards
Pipeline <i class="fa fa-external-link"></i>
Amgen Competitive Grants <i class="fa fa-external-link"></i>
Clinical Trials
Scientific Community Initiatives
Manufacturing
Overview
About Clinical Trails
Amgen Clinical Trails<i class="fa fa-external-link"></i>
Clinical Study Report Synopses<i class="fa fa-external-link"></i>
Clinical Trial Diversity
Lay Summary of Clinical Trail Result<i class="fa fa-external-link"></i>
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support program
Investigator Sponsored Studies<i class="fa fa-external-link"></i>
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities
About
Overview
Amgen History
Mission and Values
Leadership
Awards and Accolades
How We Operate
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Science
Overview
Research and Development Strategy
Pipeline
Scientific Advisory Boards
Amgen Science
Amgen Competitive Grants
Biosimilars
Clinical Trials
About Clinical Trials
Amgen Clinical Trials
Clinical Trial Diversity and Representation
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support Program
Investigator Sponsored Studies
Scientific Community Initiatives
Educational Outreach Program
Postdoctoral Fellows Program
Scientific Conferences Program
Start-Up Network Program
Manufacturing
Innovation
Quality
Reliability
PRODUCTS
Overview
Medical Information
Counterfeit Drug Statement
Safety Data Sheets
Global Patient Safety
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
Responsibility
Overview
2019 Responsibility Highlights Report
Corporate Responsibility Strategy & Governance
Amgen's Commitment to Patients
Our Approach to Pricing, Access and Affordability
Access Approaches, Treatments, and Collaborations
Transformative Treatments, Approaches and Technology
Shaping the Future of Healthcare
Access to Medicine
U.S. Reimbursement Support Services and Financial Assistance Programs
Access to Medicines Initiatives Outside the U.S.
Access to Investigational Medicines
Amgen Foundation
Amgen Inspires
About the Amgen Foundation
Programs for Teachers
Programs for Students
Amgen Foundation Grants
Commitment to Community
Staff Engagement Programs
Independent Medical Education Funding
U.S. Healthcare Donations
Non-Healthcare Donations and Sponsorships
Equipment Donations
Donation and Grant Recipients List
Diversity, Inclusion & Belonging
Amgen's Commitment to Diversity, Inclusion and Belonging
Environment
Performance
2027 Plan
Sustainable by Design
Case Studies
Responsible Sourcing
Supplier Diversity
Supplier Sustainability
Workplace
Safety
Wellness
Reporting and Metrics
Summary of Data
CDP
Stakeholder Engagement
Archived Reports
Stories
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities
Newsroom
Partners
Investors
Careers
X
Breadcrumb
Home
Investors
Search
Search
IR Menu
Investors
About
Leadership
Mission and Values
Quarterly Newsletter
News & Events
Press Releases
Presentations
Events Calendar
Annual Meeting
Financials
SEC Filings
Quarterly Earnings
Annual Reports
Tax Forms
Reconciliations
Pipeline
Stock
Stock Information
Dividend Information
Fundamentals
ESG
Corporate Governance
Responsibility
Environment
Diversity, Inclusion & Belonging
ESG FAQs
Resources
FAQs
Email Alerts
Request Information
Investor Contacts
Your selection
None
Filter by category
Filter by category
Filter by category
Filter by category
Filter by content type
SEC filing
(2576)
News
(1686)
Asset
(359)
Event
(247)
Person
(62)
Landing page
(25)
Governance committee
(5)
Filter by form group
Filter by tags
Filter by type
Search
News
Amgen Successfully Completes Acquisition Of Teneobio, Inc.
News
Amgen Announces New LUMAKRAS™ (sotorasib) Combination Data From Phase 1b CodeBreaK 101 Study In Patients With KRAS G12C-mutated Cancers At AACR-NCI-EORTC 2021
News
Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel Precision Therapies for Brain Diseases
News
Amgen Announces New Data Highlighting Global Trends In Hip Fracture Incidence And Treatment
Asset
Amgen Presentation on Inflammation Portfolio from EADV
Amgen Presentation on Inflammation Portfolio from EADV
1.9 MB
News
Amgen And Kyowa Kirin Present Positive Late-Breaking Data From Phase 2 Study Of AMG 451/KHK4083 In Adult Patients With Moderate-to-Severe Atopic Dermatitis At EADV Congress
News
Amgen To Webcast Investor Call At EADV 2021
News
FDA Approves Repatha® (evolocumab) In Pediatric Patients Age 10 And Older With Heterozygous Familial Hypercholesterolemia
News
Amgen To Present At The 2021 Cantor Global Healthcare Conference
News
Amgen Releases 8th Edition of Biosimilar Trends Report
Pagination
Page 1
Next page
››
Navbar w/ text
Investors
About
Leadership
Mission and Values
Quarterly Newsletter
News & Events
Press Releases
Presentations
Events Calendar
Annual Meeting
Financials
SEC Filings
Quarterly Earnings
Annual Reports
Tax Forms
Reconciliations
Pipeline
Stock
Stock Information
Dividend Information
Fundamentals
ESG
Corporate Governance
Responsibility
Environment
Diversity, Inclusion & Belonging
ESG FAQs
Resources
FAQs
Email Alerts
Request Information
Investor Contacts
Earnings
Show all
Q2 2021
Q2 2021 Amgen Earnings Conference Call
Q2 2021 Earnings Presentation
1.7 MB
Amgen Reports Second Quarter 2021 Financial Results
ALL RESULTS
Data as of:
Data Provided by Refinitiv. Minimum 15 minutes delayed.
MORE STOCK
